
==== Front
Adv Pharmacol Pharm Sci
Adv Pharmacol Pharm Sci
aps
Advances in Pharmacological and Pharmaceutical Sciences
2633-4682
2633-4690
Wiley

10.1155/2024/5301687
Research Article
Investigating the Medicinal Potential of Lavatera cashmeriana Leaf Extract: Phytochemical Profiling and In Vitro Evaluation of Antimicrobial, Antioxidant, and Anticancer Activities
https://orcid.org/0000-0003-0526-5457
Sofi Mohmmad Ashaq sofiashaq11@gmail.com
1
https://orcid.org/0000-0001-5643-333X
Sofi Mohd Abass 2
https://orcid.org/0000-0003-3629-7937
Nanda Anima animananda72@gmail.com
1
https://orcid.org/0009-0009-5550-2263
Thiruvengadam Kasi 3
https://orcid.org/0009-0008-0002-3890
Nayak B. K. 4
1 Department of Biomedical Engineering Sathyabama Institute of Science & Technology, Chennai 600119, Tamil Nadu, India
2 Department of Chemistry Sathyabama Institute of Science & Technology, Chennai 600119, Tamil Nadu, India
3 Biocontrol and Microbial Metabolites Lab Centre for Advanced Studies in Botany University of Madras Guindy Campus, Chennai, India
4 Department of Botany K. M. Govt. Institute for Postgraduate Studies and Research (Autonomous), Puducherry 605008, India
Academic Editor: Parasuraman Pavadai

2024
24 8 2024
2024 530168719 10 2023
29 4 2024
17 7 2024
Copyright © 2024 Mohmmad Ashaq Sofi et al.
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This study investigated the medicinal potential of Lavatera cashmeriana, a plant traditionally known for its therapeutic properties. The aim was to identify the phytocompounds in L. cashmeriana leaf extract and evaluate its antibacterial, antioxidant, and anticancer effects. Gas chromatography-mass spectrometry analysis was employed to characterize the phytochemical composition of the ethanol extract derived from L. cashmeriana leaves. The antimicrobial potential was assessed through the well diffusion technique, targeting Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans. The 2,2-diphenyl-1-picrylhydrazyl assay was conducted to assess antioxidant capabilities, while cytotoxicity against the A549 cancer cell line was determined via the MTT assay. GC-MS analysis identified ten different compounds, with phytol, 1-Eicosanol, and 2,6,10-trimethyl,14-ethylene-14-pentadecne being the most prevalent. The extract exhibited notable antimicrobial efficacy against all bacteria with MIC values ranging from 62.5 to 250 µg/mL. However, C. albicans did not respond. The extract exhibited antioxidative properties with an IC50 value of 86 µg/mL and cytotoxicity with an IC50 value of 69.95 µg/mL against the A549 cancer cell line. The results derived from this study supported the historical use of L. cashmeriana as a medicinal plant and suggested that it can potentially treat a wide range of medical ailments. The identified phytocompounds and the demonstrated antibacterial, antioxidant, and anticancer effects provide scientific evidence for its medicinal properties. However, further investigations are needed to fully understand its safety profile, efficacy, and mechanism of action before recommending it for therapeutic purposes.

University of Madras
==== Body
pmc1. Introduction

Plants have long been utilized in the treatment and alleviation of numerous illnesses. Despite the efficacy of synthetic drugs in addressing various diseases, herbal remedies are often preferred due to their fewer side effects and greater accessibility [1]. Plants contain secondary metabolites that exhibit diverse biological activities, such as antidiabetic, anticancer, antibacterial, anti-inflammatory, and antioxidant properties [2]. Gaining insight into the chemical makeup of plants is of utmost importance, as this knowledge can contribute to developing novel bioactive compounds tailored to target specific diseases [3]. Phytochemicals derived from medicinal plants are crucial as primary ingredients in the development and discovery of pharmaceuticals [4]. The primary healthcare needs of more than 80% of the global population are met through the use of plant-based remedies, as stated by the WHO [5].

Antimicrobial drug resistance has been a global concern in recent years since resistant microbes cause many health issues due to their genetic plasticity [6]. The most common pathogenic bacteria are S. aureus, P. aeruginosa, K. pneumoniae, S. typhimurium, S. epidermidis, E. coli, and C. albicans, which have been linked to antimicrobial resistance [7].

Research on relationships between plant-based antioxidants and the prevention of noncommunicable diseases, like diabetes, cancer, and cardiovascular, has increased sharply in recent years [8]. Epidemiological and in vitro investigations provide strong evidence supporting the potential use of plants containing antioxidant phytochemicals to treat various ailments. Phytochemicals, mainly phenolic compounds, have been shown to reduce oxidative stress and inhibit macromolecular oxidation, thereby decreasing the risk of degenerative diseases [9]. Consequently, there is a growing interest in identifying plant extracts that exhibit effective and nontoxic properties.

In the present era, cancer continues to be one of the most formidable illnesses, posing an imminent danger to human life. Numerous internal and external factors contribute to the onset of this disease. Despite recent strides in the development of novel anticancer medications, cancer remains a leading cause of mortality on a global scale [10]. The emergence of resistance to chemotherapy compounds further complicates the effectiveness of cancer treatment, serving as a significant obstacle. Consequently, the exploration and identification of fresh, efficacious anticancer drugs to counteract this resistance have become imperative challenges [11]. Over the past few decades, natural products have significantly contributed in the development of chemotherapeutic drugs. A noteworthy proportion of successful cancer treatments owe their success to compounds sourced from nature [10]. Approximately, 60% of the drugs presently employed in cancer treatment trace their origins back to natural sources [12].

Lavatera cashmeriana is an important medicinal herb of the Kashmir Himalayas that belongs to the Malvaceae family. Despite being native to the Kashmir valley, it is now widespread throughout the western Himalayas, from Pakistan to Uttar Pradesh and Uttaranchal. L. cashmeriana roots have been traditionally employed to address various health issues, including gastrointestinal problems, kidney stones, and dandruff. They serve as a laxative and are believed to stimulate hair growth when applied to the scalp. Traditionally, the roots of L. cashmeriana are used to treat gastrointestinal diseases, renal colic, and dandruff. The root decoction of L. cashmeriana is used as a laxative and is also said to promote hair growth when applied to the scalp. Its flowers are used to treat common colds and mumps, and its seeds are used as an antiseptic [13, 14]. The leaves and petals have been used to treat skin irritation in pregnant women, urinary issues, and as an antiseptic [15–17]. Recent research on this species has revealed some biological activities, including antilipoxygenase activity [18] as a protease inhibitor [19]. Crude extracts of medicinal plants are believed to possess higher biological activity than isolated phytocompounds due to their synergistic effects [20]. The synthesis of these secondary metabolites is genetically controlled and is strongly influenced by various biotic and abiotic stresses. Various environmental factors, such as precipitation, mean temperature, soil characteristics, and radiation, change with altitude [21, 22]. The present study aims to identify chemical constituents and assess the antimicrobial, anticancer, and antioxidant properties of the ethanolic leaf extract of L. cashmeriana.

2. Materials and Methods

2.1. Plant Collection and Processing

The plant depicted in Figure 1, L. cashmeriana, was procured from Daksum Anantnag, Jammu and Kashmir, India, in June 2019. This region is situated at an elevation of 2,438 meters (Figure 2). The plant was identified and authenticated at the Kashmir University's Center for Biodiversity and Taxonomy (CBT-botany) under voucher 3070-(KASH) Herbarium. The plant material (leaves) was subjected to a shade-drying process under hygienic conditions for a minimum of 15 days to facilitate further processing. Subsequently, an electrical grinder was used to crush the dried leaves into a coarse powder form. The resulting powder was then packaged carefully to maintain its quality and purity for future use in research.

2.2. Extraction Process

The extraction of the plant material was performed using a simple maceration process [1]. A total of 10 grams of coarse powder from the plant material was combined with 200 mL of ethanol, of a desired quality grade, in a flask. The mixture was then placed on a shaker and underwent extraction for 24 h at room temperature. After 24 h, the reaction mixture was filtered using Whatman filter paper No. 1. The obtained filtrate was further processed through solvent evaporation to get a more concentrated extract. This process was performed thrice to ensure the sample's sufficient quantity and quality for subsequent analysis.(1) Total extraction yield %=mass of the samplemass of the extract ×100.

3. GC-MS Analysis

Phytochemical profiling analysis was conducted using the GC-MS Shimadzu-QP2010. The extract was introduced to a capillary column through split mode injection with split ratio of 1 : 2. The carrier gas used was helium, and the flow rate was set at 1 mL per minute. The analysis spanned 50 minutes. Initially, the column oven was set at 80°C. Subsequently, the column temperature was gradually increased by 3°C per minute until it reached 200°C. Following this, the temperature was further elevated to 260°C at a rate of 10°C per minute and held steady for 5 minutes at that level [23].

4. List of Microbial Species

Table 1 represents the microbial species employed in the antimicrobial assay screening.

5. Antimicrobial Assay

We evaluated the antimicrobial properties of the methanolic leaf extract from L. cashmeriana against different microbes (Table 1) using the well diffusion method. Initially, sterile Muller Hinton Agar was poured into Petri dishes and allowed to solidify. Subsequently, test microorganisms were uniformly spread over the agar surface at densities ranging from 104 to 106 CFU/mL. Wells were created on the agar surface using a cork borer, and four wells were filled with varying concentrations of the L. cashmeriana extract ranging from 25 to 100 μL, each from a 10 mg/mL stock solution. The fifth and sixth wells served as the positive and negative controls, respectively. Following incubation at 37°C for 16-18 h, zones of inhibition were measured around the wells.

5.1. Determination of the MIC

The procedure was executed within 96-well plates, following the methodology outlined by Gabrielson et al. [24]. The initial ten wells of the plate accommodated diverse concentrations of L. cashmeriana leaf extract, ranging from 500 to 0.9 µg/mL. Once the wells were loaded with the extract, 5 µL of 12 h old microbial culture was introduced to each well. Subsequently, the plates were positioned within an incubator set to 37°C, where they remained for a duration of 16-18 h. Subsequent to the incubation, 10 µL of a 5 mg/mL MTT solution was incorporated into each well. MTT, a yellow dye, is transformed into a purple formazan product exclusively by viable cells. Following 2 h incubation alongside MTT, 100 µL of DMSO was introduced into each well to facilitate the dissolution of the formazan product. The visual observation of the transition in color, shifting from yellow to purple, enabled the determination of the MIC, an indicator of the lowest extract concentration entirely halting microbial proliferation.

6. Antioxidant Activity

The radical scavenging activity (RSA) of the sample was evaluated using the DPPH assay, following the methodology outlined by Chang et al. [25] with minor adjustments. In this procedure, a 0.1 mM ethanolic DPPH solution (2960 µL) was mixed with varying concentrations of the plant extract (20, 40, 60, 80, and 100 µg), alongside a blank solution composed of 0.1 mM ethanolic DPPH solution (40 µL) mixed with distilled water. The solution was vigorously mixed using a vortex mixer and afterwards placed in a dark environment at room temperature for a period of 20 minutes. Subsequently, the absorption of the mixtures was recorded at 517 nm. As a reference compound, BHT was employed. The RSA was computed using the subsequent formula: RSA (%) = (absorbance control − absorbance sample) × 100.

7. Cell Culture

The A549 human lung cancer cell line was obtained from NCCS Pune, India. These cells were cultured in DMEM (Sigma-Aldrich, United States, D1152) supplemented with 10% FBS (Gibco, United States, 10270106) and 1% antibiotic-antimycotic solution. They were maintained in an incubator at 37°C with 5% CO2. The cells were allowed to grow until they reached 70–80% confluency, indicating that they had formed a monolayer on the surface of the culture dish. Trypsinization was performed using 1× trypsin EDTA (Gibco, Catalogue: 25200-056) solution to propagate the cells further. Following trypsinization, the A549 cells were seeded into a 96-well plate and given 21-24 h to attach to the surface.

7.1. MTT Assay

In this experiment, viable cells were cultured in a 96-well plate, with each well containing a density of 6,000 cells. Extracts were prepared at various concentrations (6.5, 12.5, 25, 75, 100, and 125 μg/mL) using a culture medium. This treatment was administered over 24 and 48 h. Following the treatment period, the medium containing the extract was carefully removed and substituted with a new serum-free medium. After incubation, the MTT reagent was introduced into each well and allowed to incubate for another 4 h. The formation of formazan crystals, indicating viable cells, was facilitated by the MTT reagent. Subsequently, these crystals were solubilized using DMSO, and the absorbance was determined at 570 nm [26]. The % of cell inhibition was calculated employing the following equation:(2) % of viability=absorbance of control cellsabsorbance of treated cells×100.

7.2. Morphological Analysis

Cells were seeded onto glass coverslips in a 6-wellplate and allowed to grow until they reached a healthy morphology and achieved 60–80% confluence. Once this stage was reached, the cells were exposed to specific IC50 concentrations of L. cashmeriana leaf extract and incubated for 24 h. Upon completion of the experiment, the cells were rinsed twice with PBS. Morphological analysis was then performed using an inverted microscope (Motic type 101M).

8. Statistical Analysis

The experiments were carried out, and the data were analyzed to compute the mean ± standard deviation and IC50 values for both DPPH and MTT assays using Microsoft Excel 2019.

9. Results and Discussion

The percentage of plant extract obtained using ethanol as a solvent was assessed, and the outcomes are presented in Table 2.

The GC-MS study of the L. cashmeriana ethanolic leaf extract resulted in the identification of ten compounds (Figure 3 and Table 3).

Of these phytocompounds, the most prevailing compounds were phytol, 2,6,10-trimethyl,14-ethylene-14-pentadecane, and 1-Eicosanol. Phytol is the most prevalent and identified compound in the leaf extract of L. cashmeriana. Phytol has been investigated for its health benefits, including its ability to decrease blood sugar levels, reduce inflammation, and improve liver function. It is also commonly used in the fragrance and flavor industry and the production of vitamins and other supplements. It has also been shown to have potential as an antimicrobial, anticancer agent, as it has been found to induce apoptosis in cancer cells [27].

The emergence of antibiotic resistance and new pathogens has made treating bacterial infections more challenging. Therefore, finding new and effective bioactive agents to combat microbial infections is urgently needed. Despite the availability of numerous drugs for treating microbial infections, their adverse side effects can limit their usage in specific populations, making it difficult to treat microbial infections, especially in vulnerable populations [28, 29]. Plant extracts are active against various pathogenic microorganisms, including S. typhi, E. coli, P. aeruginosa, C. albicans, S. aureus, and B. subtilis, among others. As a result, researchers continue to explore the potential of plant extracts as a source of new and effective bioactive agents to treat bacterial infections [30]. L. cashmeriana, a medicinal plant commonly used in traditional remedies by local inhabitants, was tested against different microbial strains to evaluate and examine its antimicrobial capabilities. The crude ethanolic leaf extract of L. cashmeriana demonstrated the highest antimicrobial activity against E. coli 19 ± 0.57 mm, E. faecalis 16 ± 0.63 mm, followed by P. aeruginosa 14 ± 0.45 mm and S. aureus 11 ± 0.45 mm with MIC values ranging from 62.5 to 250 μg/mL. However, the extract did not exhibit antifungal activity against C. albicans, indicating that it may not be effective against infections caused by this microbe, as shown in Figure 4 and Table 4, with zones of inhibition and MIC values, respectively. The results from this research align with findings from previous studies on the Lavatera genus and Malvaceae family, which also demonstrated significant antimicrobial activity against various microorganisms [31–34]. Skalicka-Woźniak et al. [31] found that the chloroform extract of L. trimestris exhibited considerable antibacterial activity against S. aureus, E. coli, and P. aeruginosa. Similarly, Sofi et al. [34] found strong activity against E. coli, P. aeruginosa, S. aureus, and E. faecalis in the methanolic root extract of L. cashmeriana. Despite the promising antibacterial potential of L. cashmeriana, its leaf extract did not exhibit activity against C. albicans. This observation was consistent with other studies on L. cashmeriana methanolic root, ethanolic extract from leaves of Lavatera arborea L, and ethanolic extract of aerial parts of Sida acuta, which also demonstrated no activity against C. albicans [34, 35]. These results highlight the need for further research to identify plant extracts with both antibacterial and antifungal properties to combat a broader range of infections effectively.

The findings of this study are encouraging, as the examined microbes commonly cause community- and hospital-acquired infections. The growing antibiotic resistance underscores the need for new drugs with novel targets. The antimicrobial activity of L. cashmeriana is relevant in this perspective since the MIC values of the active extract in the present investigation are below 1 mg/mL, which may be regarded as significant in light of the discovery of potent antimicrobials from plants.

The generation of free radicals causes several reactions that may harm tissues, cell function, and macromolecules [36]. Oxidative stress has been linked to several pathological disorders, including aging, atherosclerosis, diabetes, and cancer [37]. Nonetheless, antioxidants provide a promising defense against oxidative stress-related diseases by slowing the rate of oxidation or inhibiting the propagation of free radical production, resulting in anticancer, anti-aging, and anti-inflammatory properties [38]. The antioxidant property of crude extract was assessed using the DPPH radical scavenging test in this study. The findings of this assay are shown in Figure 5, which compared the DPPH radical scavenging activity of L. cashmeriana leaf extract to that of ascorbic acid. Although the standard antioxidant had more scavenging activity than the extract at all tested concentrations, the extract nonetheless demonstrated considerable free radical scavenging activity. One of the methods through which L. cashmeriana is beneficial as traditional medicine is its ability to scavenge free radicals. Consumption of L. cashmeriana leaves may help in preventing oxidative stress-related degenerative illnesses. The antioxidant activity of L. cashmeriana might be due to the presence of flavonoid and phenolic compounds. Phenolic and flavonoid compounds have been linked to antioxidative activity in biological systems, serving as scavengers of free radicals [39]. Consumption of L. cashmeriana leaves may help in preventing oxidative stress-related degenerative illnesses.

Cancer has become a significant cause of mortality in underdeveloped nations, surpassing AIDS, TB, and malaria combined. Lung cancer is a particularly prevalent type, leading to a large number of deaths worldwide [40, 41]. Although synthetic chemistry has recently dominated drug discovery and production, plant-derived medications have significantly impacted the antitumor field. In light of this, the potential of bioactive plants and their extracts to provide innovative disease treatment and prevention solutions remains immense. Some of the notable plant-derived agents that have improved chemotherapy for various types of cancer include taxol, vinblastine, camptothecin, and vincristine [42]. The vast potential of plants to produce chemicals attracts researchers seeking new and novel chemotherapeutic agents [43]. As a result, exploring anticancer chemicals in plants and traditional foods is a promising and viable cancer prevention strategy [44]. Plant-based compounds with anticancer properties can be found in several categories, such as terpenoids, phenylpropanoids, and alkaloids [45]. Continued research into these compounds holds excellent potential for the development of new, effective treatments for cancer, especially in underdeveloped nations where access to conventional therapies might be limited.

Harnessing the power of plants and their extracts can revolutionize cancer treatment and prevention, offering hope to millions of patients worldwide. Many plant-derived medicines are effective in treating different types of cancer. Plant-derived medicines often have advantages, including better patient tolerance and fewer negative side effects in comparison to their synthetic counterparts. In addition, the development of drug resistance is less common with plant-derived medications [43, 46].

In the past, extracts and isolated components derived from plants belonging to the Malvaceae family have shown noteworthy effectiveness in inhibiting the growth of cancerous cells. This current investigation focused on evaluating the impact of an ethanol-based leaf extract from L. cashmeriana on A549 cells. The extract was found to be cytotoxic to A549 cells, with an IC50 value of 69.95 µg/mL compared to control (Figure 6). The cytotoxicity increased with an increase in extract concentration, as observed in the MTT results. The study suggests that the ethanolic extract of L. cashmeriana leaves showed strong anticancer activity against A549 cells in a dose-dependent manner. Thus, it has the potential for use in cancer prevention and chemotherapy. Earlier research has documented the in vitro potential of extracts from the same family to exhibit antilung cancer properties. Rakshanda et al. [47] studied the impact of L. cashmeriana protease inhibitors (LC-pi) isolated from seed on A549 cell proliferation. LC-pi I and II inhibited A549 cell growth. These compounds showed concentration-dependent inhibitory actions. After 48 h, IC50 values for LC-pi I and II were 54 μg/mL and 38 μg/mL, respectively. In related studies, the different extracts of Hibiscus sabdariffa Linn demonstrated anticancer activities against A549 cells, with the ethanolic extract being the most potent (IC50 value of 374.01 μg/mL) [48]. Similarly, the ethanolic leaf extract of Abutilon indicum L exhibited antiproliferative effects against the A549 cells, with an IC50 value of 85.2 µg/mL [49]. In another study, the antiproliferative efficacy of the methanolic extract of different parts of Grewia orbiculata plant was assessed on the A549 lung cancer cell line, revealing an IC50 value of 98.73 µg/mL [50]. Furthermore, the ethanolic leaf extract derived from A. indicum demonstrated notable antiproliferative effects against the A549 cell line, achieving a substantial cell inhibition rate of 72.1% at a concentration of 200 μg/mL [51]. Our findings align with these earlier studies, suggesting that the ethanolic extract could be a promising candidate for further research and development of anti lung cancer therapies. While preliminary studies have shown promising anticancer properties of L. cashmeriana, further research is essential to validate these findings and explore the underlying molecular mechanisms responsible for its anticancer effects.

The impact of L. cashmeriana extract on the structure of A549 cells was investigated. In the control group, cells displayed regular growth patterns with distinct nuclei. Furthermore, control cells exhibited excellent adherence in a single layer, whereas the treated cells displayed atypical structure and distorted cell membranes, as evidenced by microscopic analysis (Figures 7(a) and 7(b)). These treated cells demonstrated signs of shrinkage and distorted membranes, consistent with the attributes of cells undergoing apoptosis, as previously documented by researchers [52, 53].

The antimicrobial, antioxidant, and antiproliferative properties of the ethanolic leaf extract of L. cashmeriana can be attributed to bioactive compounds. Some of the major compounds identified in our study, phytol, biphenyl, 1-Eicosanol, and 1,2-Benzenedicarboxylic acid 3-nitro, have been shown to exhibit antimicrobial and antioxidant properties [27, 54–57]. Phytol, 2,6,10-trimethyl-14-ethylene-14-pentadecene, and butyl 9,12,15-octadecatrienoate are reported to display antiproliferative properties [58–60].

Phytol, the predominant compound in the ethanolic extract of L. cashmeriana, has been shown to hinder angiogenesis and enhance cell death in A549 cells by altering the mitochondrial membrane potential [61, 62]. In a separate investigation, it was observed that phytol triggered both apoptosis and protective autophagy in AGS cells. The autophagy inhibitor CQ intensified phytol's inhibitory impact on cell proliferation and facilitated apoptosis in gastric cancer cells [63]. Likewise, phytol induces apoptotic alterations and generates ROS in A549 cells by activating TRAIL, FAS, and TNF-α receptors, along with caspase 9 and 3 [64]. Phytol has been identified as an inducer of ROS-mediated apoptosis in S. pombe. In addition, it has been confirmed that phytol effectively inhibits cellular senescence caused by oxidative stress from H2O2 [65, 66].

Thorough investigations of the above analytical compounds present in this plant reveal tremendous medical significance, owing to the presence of varied phytoconstituents, which can treat various diseases and potentially serve as precursor compounds for numerous medicinal and other applications.

10. Conclusion

In conclusion, this research article highlighted the medicinal potential of L. cashmeriana, a plant traditionally used for its therapeutic properties. The study identified ten compounds in the ethanol extract of L. cashmeriana leaves, with phytol, 1-Eicosanol, 2,6,10-trimethyl, and 14-ethylene-14-pentadecane being the most prevalent. The extract exhibited antimicrobial efficacy against E. coli, E. faecalis, P. aeruginosa, and S. aureus. However, it did not affect C. albicans. In addition, the extract showed antioxidant properties and a strong cytotoxic effect on the A549 cancer cell line. These positive outcomes necessitate further research to elucidate the mechanisms behind these effects, including the safety and efficacy of the extract in vivo, as well as the exploration of novel therapeutic agents from its active components for the treatment of infectious diseases and cancer.

Acknowledgments

The authors acknowledge the University of Madras, Guindy Campus, and Sathyabama Institute of Science &Technology, Chennai, for providing the necessary laboratory facilities for conducting the experiments.

Data Availability

All relevant data for this research are provided in the manuscript.

Disclosure

No artificial intelligence (AI) tools or systems were used in the preparation and writing of this work.

Conflicts of Interest

The authors state that there are no conflicts of interest.

Authors' Contributions

M.A.S. wrote the original draft, investigated the study, proposed the methodology, performed formal analysis, reviewed and edited the manuscript, performed data curation, provided resources and software, performed project administration, and conceptualized the study. A.N. supervised the study, reviewed and edited the manuscript, and visualized the study. K.T. provided software and resources and reviewed and edited the manuscript. B.K.N. supervised the study, visualised the study, validated the study, and reviewed and edited the manuscript. All the authors have read and agreed to the published version of the manuscript. All research, analysis, and writing were conducted manually by the authors.

Figure 1 Lavatera cashmeriana plant.

Figure 2 Site at Anantnag Daksum, Kashmir.

Figure 3 Chromatogram of L. cashmeriana ethanolic leaf extract.

Figure 4 The well diffusion method for determining the antibacterial property of ethanolic leaf extract of L. cashmeriana. The numbers given to each Petri dish denote the wells that contain various concentrations of L. cashmeriana leaf extract, standard medications at 25 µL (1 mg/mL), and negative control. The specific concentrations are as follows: 1 : 25 µL; 2 : 50 µL; 3 : 75 µL; 4 : 100 µL; 5 : 25 µL. The positive control consists of Ampilox for Gram-positive bacteria, Fluconazole for fungi, and Ciprofloxacin for Gram-negative bacteria (labeled as 6). In addition, DMSO: negative control.

Figure 5 The capacity of ethanolic leaf extract of L. cashmeriana and ascorbic acid to neutralize DPPH radicals is depicted at various concentrations. Each value displayed represents the mean ± SD, based on three repetitions (n = 3).

Figure 6 MTT assay of A549 cells treated with L. cashmeriana ethanolic leaf extract. The error bars depict the standard deviation from the mean. n = 3.

Figure 7 (a, b) The morphology of A549 cells in two groups: the control group (a) and the group treated with the IC50 value (b). The cells treated with the IC50 value (b) demonstrate noticeable characteristics such as shrinkage and deformed membranes.

Table 1 The microbial species employed in the antimicrobial assay screening.

Test organism	Source	Microbial type	
E. faecalis	ATCC 25923	Gram positive	
S. aureus	ATCC 29212	Gram positive	
E. coli	ATCC 11229	Gram negative	
P. aeruginosa	ATCC 15442	Gram negative	
C. albicans	ATCC 10231	Fungus	

Table 2 The yield of extraction of L. cashmeriana in ethanol.

Species	Mass of the dried leaf (g)	Mass of the extract (g) yield %	
L. cashmeriana	10	1.421 (14.21%)	

Table 3 Phytocompounds reported in the ethanolic leaf extract of L. cashmeriana by GC-MS.

Peak#	R. time	Area%	Name	Molecular formula	Molecular weight	
1	12.435	5.44	Biphenyl	C12H10	154	
2	28.802	16.69	2,6,10-Trimethyl,14-ethylene-14-pentadecne	C20H38	278	
3	28.945	2.93	2-Pentadecanone,6,10,14-trimethyl-	C18H36O	268	
4	29.632	4.62	3,7,11,15-Tetramethyl-2-hexadecen-1-ol	C20H40O	296	
5	30.232	6.92	2,6,10-Trimethyl,14-ethylene-14-pentadecne	C20H38	278	
6	33.758	2.95	2A-Hydroxymanoyloxide	C20H34O2	306	
7	37.344	33.56	Phytol	C20H40O	296	
8	38.763	4.61	Ethyl(9Z,12Z)-9,12-octadecadienoate	C20H36O2	308	
9	45.055	4.26	Butyl9,12,15-octadecatrienoate	C22H38O2	334	
10	46.023	5.10	1,2-Benzenedicarboxylic acid, 3-nitro-	C24H38O4	390	
11	48.736	8.93	1-Eicosanol	C20H42O	298	
12	50.543	4.00	2,6,10,14,18-Pentamethyl 2,6,10,14,18-Icosapentaene	C25H42	342	
 	 	100.00	 	 	 	

Table 4 The zone of inhibition of the ethanolic leaf extract of L. cashmeriana against microorganisms.

Zone of inhibition (mm)	
Plant extract stock solution 10 mg/mL	1 mg/mL standard drug	
Ampilox/ciprofloxacin, fluconazole	
Microbe names	25 µL	50 µL	75 µL	100 µL	25 µL	DMSO	
E. faecalis	—	—	12 ± 0.4	16 ± 0.6	17 ± 0.7	—	
S. aureus	—	—	11 ± 0.6	14 ± 0.4	18 ± 0.8	—	
C. albicans	—	—	—	—	—	—	
E. coli	12 ± 0.5	16 ± 0.7	18 ± 0.8	19 ± 0.6	36 ± 0.4	—	
P. aeruginosa	—	—	12 ± 0.4	14 ± 0.5	34 ± 0.6	—	
	
Gram-positive bacteria	MIC (µg/mL)
Gram-negative bacteria	Fungus	
	
E. faecalis	S. aureus	P. aeruginosa	E. coli	C. albicans	
125	250	250	62.5	ND	
The symbol — denotes no activity, and the reported value represents the mean ± SD obtained from three repetitions (n = 3). ND: not determined, as they did not show antimicrobial activity in the well diffusion assay.
==== Refs
1 Theyyathel A. M. Sofi M. A. Nanda A. Phytochemical profiling, antimicrobial and anticancer potential of Rosmarinus officinalis growing in Kashmir Himalayan region Journal of Applied and Natural Science 2023 15 2 560 569 10.31018/jans.v15i2.4201
2 Ralte L. Khiangte L. Thangjam N. M. Kumar A. Singh Y. T. GC–MS and molecular docking analyses of phytochemicalsfrom the underutilized plant, Parkia timoriana revealed candidate anti-cancerous and anti-inflammatory agents Scientific Reports 2022 12 1 p. 3395 10.1038/s41598-022-07320-2 35233058
3 Cragg G. M. Newman D. J. Natural products: a continuing source of novel drug leads Biochimica et Biophysica Acta (BBA) - General Subjects 2013 1830 6 3670 3695 10.1016/j.bbagen.2013.02.008 2-s2.0-84876002671 23428572
4 Aware C. B. Patil D. N. Suryawanshi S. S. Natural bioactive products as promising therapeutics: A review of natural product-based drugdevelopment South African Journal of Botany 2022 151 512 528 10.1016/j.sajb.2022.05.028
5 Gupta S. Bishnoi J. P. Phytochemical screening of Terminalia arjuna and Glycyrrhiza glabra showing the effect of different drying techniques Research Journal of Pharmacy and Technology 2019 12 4 1566 1568 10.5958/0974-360x.2019.00259.2 2-s2.0-85073432859
6 Uddin T. M. Chakraborty A. J. Khusro A. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and futureprospects Journal of Infection and Public Health 2021 14 12 1750 1766 10.1016/j.jiph.2021.10.020 34756812
7 Bao L. Peng R. Ren X. Ma R. Li J. Wang Y. Analysis of some common pathogens and their drug resistance to antibiotics Pakistan Journal of Medical Sciences 2013 29 1 135 139 10.12669/pjms.291.2744 2-s2.0-84930480813 24353525
8 Grosso G. Dietary antioxidants and prevention of non-communicable diseases Antioxidants 2018 7 7 p. 94 10.3390/antiox7070094 2-s2.0-85050943035
9 Pandey K. B. Rizvi S. I. Plant polyphenols as dietary antioxidants in human health anddisease Oxidative Medicine and Cellular Longevity 2009 2 5 270 278 10.4161/oxim.2.5.9498 2-s2.0-77953474824 20716914
10 Choudhari A. S. Mandave P. C. Deshpande M. Ranjekar P. Prakash O. Phytochemicals in cancer treatment: from preclinical studies to clinical practice Frontiers in Pharmacology 2019 10 p. 1614 10.3389/fphar.2019.01614
11 Talib W. H. Alsayed A. R. Barakat M. Abu-Taha M. I. Mahmod A. I. Targeting drugchemo-resistance in cancer using natural products Biomedicines 2021 9 10 p. 1353 10.3390/biomedicines9101353 34680470
12 Ali Abdalla Y. O. Subramaniam B. Nyamathulla S. Natural products for cancer therapy: a review of their mechanism of actions and toxicity in the past decade Journal of Tropical Medicine 2022 2022 1 20 10.1155/2022/5794350
13 Wani S. Kaloo Z. A. Shah M. A. An efficient in vitro regeneration protocol from leaf explant of Lavatara cashmeriana Cambess: an important endemic medicinal herb of Kashmir Himalaya Discovery Agriculture 2018 4 52 60
14 Kaul M. K. Medicinal Plants of Kashmir and Ladhak 1997 New Delhi, India Indus Publishing Co
15 Hassan G. A. Ahmad T. B. Din Mohi-Ud-R. An ethnobotanical study in Budgam district of Kashmir valley: An attempt to explore and document traditional knowledge of the area International Research Journal of Pharmacy 2013 4 1 201 204
16 Ballabh B. Chaurasia O. P. Ahmed Z. Singh S. B. Traditional medicinal plants of cold desert Ladakh—used against kidney and urinary disorders Journal of Ethnopharmacology 2008 118 2 331 339 18550306
17 Malik A. H. Khuroo A. A. Dar G. H. Khan Z. A. Ethnomedicinal uses of some plants in the Kashmir Himalaya. Indian J. Tradit. Knowl. 10, 362-366akh—used against kidney and urinary disorders Journal of Ethnopharmacology 2011 118 331 339
18 Khattak S. Rehman S. U. UllahShah H. Khan T. Ahmad M. In vitro enzyme inhibitionactivities of crude ethanolic extracts derived from medicinal plants of Pakistan Natural Product Research 2005 19 567 657 16010821
19 Rakashanda S. Mubashir S. Qurishi Y. Hamid A. Masood A. Amin S. Trypsin inhibitors from Lavatera cashmeriana Camb. Seeds: Isolation, characterization and in-vitro cytoxicity activity IJPSI 2013 5 55 65
20 Rasoanaivo P. Wright C. W. Willcox M. L. Gilbert B. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions Malaria Journal 2011 10 S1 S4 S12 10.1186/1475-2875-10-s1-s4 2-s2.0-79952758442 21411015
21 Qaderi M. M. Martel A. B. Strugnell C. A. Environmental factors regulate plant SecondaryMetabolites Plants 2023 12 3 p. 447 10.3390/plants12030447
22 Yeshi K. Crayn D. Ritmejerytė E. Wangchuk P. Plant secondary metabolites produced in response to abiotic stresses has potential application in pharmaceutical product development Molecules 2022 27 1 p. 313 10.3390/molecules27010313
23 Vasantharaja R. Abraham L. S. Inbakandan D. Influence of seaweed extracts on growth, phytochemical contents and antioxidant capacity of cowpea (Vigna unguiculata L. Walp) Biocatalysis and Agricultural Biotechnology 2019 17 589 594 10.1016/j.bcab.2019.01.021 2-s2.0-85060349112
24 Gabrielson J. Hart M. Jarelöv A. Kühn I. McKenzie D. Möllby R. Evaluation of redox indicators and the use of digital scanners and spectrophotometer for quantification of microbial growth in microplates Journal of Microbiological Methods 2002 50 1 63 73 10.1016/s0167-7012(02)00011-8 2-s2.0-0036212454 11943359
25 Chang S. T. Wu J. H. Wang S. Y. Kang P. L. Yang N. S. Shyur L. F. Antioxidant activity of extracts from Acacia confusa bark and heartwood Journal of Agricultural and Food Chemistry 2001 49 7 3420 3424 10.1021/jf0100907 2-s2.0-0034853244 11453785
26 Sofi M. A. Nanda A. Sofi M. A. Sheikh T. Rather G. A. In vitro evaluation of antimicrobial and anticancer potential of Artemisia absinthium growing in Kashmir Himalayas Journal of Applied and Natural Science 2022 14 3 895 902 10.31018/jans.v14i3.3619
27 Islam M. T. Ali E. S. Uddin S. J. Phytol: a review of biomedical activities Food and Chemical Toxicology 2018 121 82 94 10.1016/j.fct.2018.08.032 2-s2.0-85052092268 30130593
28 Mulat M. Khan F. Muluneh G. Pandita A. Phytochemical profile and antimicrobial effects of different medicinal plant: current knowledge and future perspectives Current Traditional Medicine 2020 6 1 24 42 10.2174/22150838mtaw5mdqe1
29 Figuerêdo J. S. D. Santos F. P. Furtado P. V. Natural products from plants with antimicrobial action Promising Antimicrobials from Natural Products 2022 Cham, Switzerland Springer 183 198
30 Haruna A. Yahaya S. M. Recent advances in the chemistry of bioactive compounds from plants and soil microbes: a review Chemistry Africa 2021 4 2 231 248 10.1007/s42250-020-00213-9
31 Skalicka-Woźniak K. Melliou E. Gortzi O. Glowniak K. Chinou I. B. Chemical constituents of Lavatera Trimestris L.–antioxidant and antimicrobial activities Zeitschrift für Naturforschung C 2007 62 11-12 797 800 10.1515/znc-2007-11-1204 2-s2.0-38549114745
32 Razavi S. M. Zarrini G. Molavi G. Ghasemi G. Bioactivity of Malva sylvestris L., a medicinal plant from Iran Iranian Journal of Basic Medical Sciences 2011 14
33 Zhandabayeva M. A. Kozhanova K. K. Boshkayeva A. K. Determination of the chemical composition and antimicrobial activity of Lavatera thuringiaca L. Medicinal herb material extracted under Subcritical conditions by the liquid carbon dioxide method International Journal of Biomaterials 2021 2021 10 7541555 10.1155/2021/7541555
34 Sofi M. A. Nanda A. Raj E. Sofi M. A. Phytochemical profiling of the methanolic root extract of Lavatera’ cashmeriana using GC-MS and evaluation of its potential antimicrobial activity Research Journal of Pharmacy and Technology 2022 15 12 5707 5713 10.52711/0974-360x.2022.00962
35 Rojas R. Bustamante B. Bauer J. Fernández I. Albán J. Lock O. Antimicrobial activity of selected Peruvian medicinal plants Journal of Ethnopharmacology 2003 88 2-3 199 204 10.1016/s0378-8741(03)00212-5 2-s2.0-0041829133 12963143
36 Martemucci G. Costagliola C. Mariano M. D’andrea L. Napolitano P. D’Alessandro A. G. Free radical properties, source and targets, antioxidant consumption and health Oxygen 2022 2 2 48 78 10.3390/oxygen2020006
37 Liguori I. Russo G. Curcio F. Oxidative stress, aging, and diseases Clinical Interventions in Aging 2018 13 757 772 10.2147/cia.s158513 2-s2.0-85047073565 29731617
38 Dhalaria R. Verma R. Kumar D. Bioactive compounds of edible fruits with their anti-aging properties: a comprehensive review to prolong human life Antioxidants 2020 9 11 p. 1123 10.3390/antiox9111123 33202871
39 Huyut Z. Beydemir Ş. Gülçin İ. Antioxidant and antiradical properties of selected flavonoids and phenolic compounds Biochemistry Research International 2017 2017 10 7616791 10.1155/2017/7616791 2-s2.0-85042227487
40 Hamdi Y. Abdeljaoued-Tej I. Zatchi A. A. Cancer in Africa: the untold story Frontiers in Oncology 2021 11 650117 10.3389/fonc.2021.650117
41 Chaitanya Thandra K. Barsouk A. Saginala K. Sukumar Aluru J. Barsouk A. Epidemiology of lung cancer Współczesna Onkologia 2021 25 1 45 52 10.5114/wo.2021.103829 33911981
42 Newman D. J. Cragg G. M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019 Journal of Natural Products 2020 83 3 770 803 10.1021/acs.jnatprod.9b01285 32162523
43 Atanasov A. G. Zotchev S. B. Dirsch V. M. Supuran C. T. Natural products in drug discovery: advances and opportunities Nature Reviews Drug Discovery 2021 20 3 200 216 10.1038/s41573-020-00114-z 33510482
44 Huang M. Lu J. J. Ding J. Natural products in cancer therapy: past, present andfuture Natural products and bioprospecting 2021 11 1 5 13 10.1007/s13659-020-00293-7 33389713
45 Singh A. Singh D. K. Kharwar R. N. White J. F. Gond S. K. Fungal endophytes as efficient sources of plant-derived bioactive compounds and their prospective applications in natural product drug discovery: insights, avenues, and challenges Microorganisms 2021 9 1 p. 197 10.3390/microorganisms9010197
46 Hassan B. Plants and Cancer Treatment 2020 London, UK IntechOpen
47 Rakashanda S. Qazi A. K. Majeed R. Plant-derived protease inhibitors LC-pi (Lavatera Cashmeriana) inhibit human lung cancer cell proliferation in vitro Nutrition and Cancer 2015 67 1 156 166 10.1080/01635581.2015.967876 2-s2.0-84920507791 25412192
48 Fithrotunnisa Q. Arsianti A. Kurniawan G. Qorina F. Tejaputri N. A. Azizah N. N. In vitro cytotoxicity of Hibiscus sabdariffa Linn extracts on A549 lung cancer cell line Pharmacognosy Journal 2020 12 1 14 19 10.5530/pj.2020.12.3
49 Swathi Saranya K K. D. Saranya K. S. Vadlapudi V. Yarla N. S. Evaluation of anti-inflammatory and anti-proliferative activity of Abutilon indicum L. Plant ethanolic leaf extract on lung cancer cell line A549 for system network studies Journal of Cancer Science & Therapy 2014 06 06 195 201 10.4172/1948-5956.1000271 2-s2.0-84904709221
50 Suguna M. Umesha S. HR-LCMS Profiling of phytochemical constituents and evaluation of antioxidant, antibacterial, anti-cancerous and anti-inflammatory potentials, plasma biocompatibility and cytotoxicity of Grewia orbiculataRottler Vegetos 2023 36 4 1446 1457 10.1007/s42535-022-00530-z
51 Kaushik D. Khokra S. L. Kaushik P. Sharma C. Aneja K. R. Evaluation of antioxidant and antimicrobial activity of Abutilon indicum Pharmacologyonline 2010 1 102 108
52 Hadisaputri Y. E. Habibah U. Abdullah F. F. Antiproliferation activity and apoptotic mechanism of soursop (Annona muricata L.) leaves extract and fractions on MCF7 breast cancer cells Breast Cancer: Targets and Therapy 2021 13 447 457 10.2147/bctt.s317682 34295188
53 Villarini M. Acito M. di Vito R. Pro-apoptotic activity of artichoke leaf extracts in human HT-29 and RKO colon cancer cells International Journal of Environmental Research and Public Health 2021 18 8 p. 4166 10.3390/ijerph18084166
54 Wang X. Fu H. Y. He W. Synthesis and antibacterial activity evaluation of Biphenyl and dibenzofuran derivatives as potential antimicrobial agents against antibiotic-resistant bacteria Current Issues in Molecular Biology 2022 44 9 4087 4099 10.3390/cimb44090280 36135192
55 Arora S. Meena S. GC-MS Profiling of Ceropegia bulbosa Roxb. var. bulbosa, an endangered plant from Thar Desert, Rajasthan The Pharma Innovation Journal 2017 6 11 568 573
56 Sher A. A. Iqbal A. Adil M. GC-MS analysis of organic fractions of Chrozophora tinctoria (L.) A. Juss. and their prokinetic propensity in animal models Brazilian Journal of Biology 2022 84 e260566 10.1590/1519-6984.260566
57 Beulah G. G. Soris P. T. Mohan V. R. GC-MS determination of bioactive compounds of Dendrophthoe falcata (LF) Ettingsh: an epiphytic plant International Journal of Health Sciences & Research 2018 8 261 269
58 Daudin J. B. Monnet D. Kavian N. Protective effect of pristane onexperimental autoimmune uveitis Immunology Letters 2011 141 1 83 93 10.1016/j.imlet.2011.07.009 2-s2.0-80955158426 21896286
59 Selvamangai G. Bhaskar A. GC–MS analysis of phytocomponents in the methanolic extract of Eupatorium triplinerve Asian Pacific Journal of Tropical Biomedicine 2012 2 3 S1329 S1332 10.1016/s2221-1691(12)60410-9 2-s2.0-84875398798
60 Devakumar J. Keerthana V. S. S. S. Sudha S. S. Identification of bioactive compounds by gas chromatography-mass spectrometry analysis of Syzygiumjambos (L.) collected from Western Ghats region Coimbatore, Tamil Nadu Asian Journal of Pharmaceutical and Clinical Research 2017 10 1 364 369
61 de Alencar M. V. O. B. Islam M. T. de Lima R. M. T. Phytol as an anticarcinogenic and antitumoral agent: Anin vivo study in swiss mice with DMBA‐Induced breast cancer IUBMB Life 2019 71 2 200 212 10.1002/iub.1952 2-s2.0-85055917988 30394663
62 Sakthivel R. Malar D. S. Devi K. P. Phytol shows anti-angiogenic activity and induces apoptosis in A549 cells by depolarizing the mitochondrial membrane potential Biomedicine and Pharmacotherapy 2018 105 742 752 10.1016/j.biopha.2018.06.035 2-s2.0-85048395928 29908495
63 Song Y. Cho S. K. Phytol induces apoptosis and ROS-mediated protective autophagy in human gastric adenocarcinoma AGS cells Biochemistry & Analytical Biochemistry 2015 4 4 p. 1
64 Thakor P. Subramanian R. B. Thakkar S. S. Ray A. Thakkar V. R. Phytol induces ROS mediated apoptosis by induction of caspase 9 and 3 through activation of TRAIL, FAS and TNF receptors and inhibits tumor progression factor Glucose 6 phosphate dehydrogenase in lung carcinoma cell line (A549) Biomedicine and Pharmacotherapy 2017 92 491 500 10.1016/j.biopha.2017.05.066 2-s2.0-85020029119 28575806
65 Thakor P. Mehta J. B. Patel R. R. Patel D. D. Subramanian R. B. Thakkar V. R. Extraction and purification of phytol from Abutilon indicum: cytotoxic and apoptotic activity RSC Advances 2016 6 54 48336 48345 10.1039/c5ra24464a 2-s2.0-84971353870
66 Jeong S. H. Inhibitory effect of phytol on cellular senescence Biomedical Dermatology 2018 2 1 13 19 10.1186/s41702-018-0025-8
